Last reviewed · How we verify
NCT04676503
Vaginal and Rectal Colonization of Lactobacillus Crispatus NTCVAG04 Following Oral Administration in Patients With History of Vaginitis/Vaginosis
NA trial testing BIOVAGINIL in Vaginitis in 20 participants. Completed in 21 July 2020.
27 May 2020
Quick facts
| Lead sponsor | NTC srl |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 22 November 2019 |
| Primary completion | 27 May 2020 |
| Estimated completion | 21 July 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- BIOVAGINIL
Conditions studied
Sponsor
NTC srl — full company profile →
Who can join
18 and older, female only, with Vaginitis or Vaginosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to identify the presence of L. Crispatus in the rectum and vagina after oral administration of BIOVAGINIL by searching for specific DNA of the bacterial strain, to evaluate the tolerability of BIOVAGINIL and evaluate the minimum duration of the oral administration necessary to determine the appearance of L. Crispatus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04676503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaginitis
Currently open trials in the same condition.
- NCT06771063 — A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients · Phase 2 · recruiting
- NCT06070454 — Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant L · NA · recruiting
- NCT04574089 — Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository · Phase 3 · recruiting
Other NTC srl trials
Trials by the same sponsor.
- NCT07465705 — Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY) · Phase 3 · recruiting
- NCT06616922 — Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults · Phase 2 · completed
- NCT04759885 — Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® · Phase 2, PHASE3 · completed
- NCT03740659 — Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Catarac · Phase 2 · completed
- NCT03739528 — Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04676503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NTC srl
- Last refreshed: 21 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04676503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing